SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Regeneron Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?


To: keokalani'nui who wrote (543)6/28/2001 8:02:43 PM
From: Miljenko Zuanic  Read Replies (1) | Respond to of 3557
 
Yes, this is the same drug.

You can not draw conclusion on efficacy and safety from single dose. As you know IMNX is reformulating Nuvance (IL-4sR).

If one think about *problems* DNA have with Xolair, than anti-IL-X/Y may be the first break true in new approach to treat asthma.

However, REGN is veeeerrrryyyy SLOOOWWWWW with their IL-4/13 combination trap. Seams forever! :(

Miljenko